[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"exfoliation-syndrome\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:exfoliation-syndrome":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":31,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":5},"100569231","long-term-safety-and-efficacy-of-a-modified-suprachoroidal-silicone-tube-sst-shunt-100569231",false,"NCT06691555","Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt","The Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt in Patients with Primary Open-angle Glaucoma (POAG) and Pseudo-exfoliative Glaucoma (PXG) Over an Extended Follow-up Period","Inclusion Criteria:\n\n* Previously were treated with Suprachoroidal silicone tube shunt\n* Willing and able to participate in this cross sectional observational follow up\n* Participant capable of giving informed consent\n\nExclusion Criteria:\n\n* Condition that could impact the ability of the participant to attend a follow-up visit as per the discretion of the investigator","ALL","40 Years","90 Years",{"count":20,"type":21},66,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to evaluate the long-term safety and efficacy of a modified suprachoroidal silicone tube (SST) shunt in treating patients with primary open-angle glaucoma (POAG) and pseudo-exfoliative glaucoma (PXG).\n\nThe main questions it aims to answer are:\n\nDoes the SST shunt maintain intraocular pressure (IOP) reduction over an extended follow-up period? What is the effect of the SST shunt on endothelial cell count (ECC) and overall corneal health?\n\nParticipants will:\n\nUndergo intraocular pressure (IOP) measurements Have their endothelial cell count (ECC) evaluated Complete assessments of best corrected visual acuity (BCVA) Be assessed for C\u002FD ratio Be monitored for adverse events or shunt-related complications over time",[25,26,27,28,29,30],"Glaucoma","Open Angle Glaucoma (OAG)","POAG","Ocular Hypertension","Exfoliation Syndrome","Choroidal Effusions",[32,33,25,34,35,36,37],"MIGS","Suprachoroidal Space","Open-Angle Glaucoma","Suprachoroidal Silicone Tube","Suprachoroidal Shunt","Glaucoma Shunt","RECRUITING","2024-11-14",{"date":41,"type":42},"2024-11-15","ACTUAL",{"date":44,"type":42},"2024-11-08",{"date":46,"type":21},"2024-11-30",{"name":48,"class":49},"Davinci LTD","OTHER"]